These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32852651)

  • 41. Familial chylomicronemia syndrome caused by compound heterozygous mutation of lipoprotein lipase gene: A case report and review of literature.
    Huang Y; Qin Y; Liao L; Lin F
    Clin Chim Acta; 2022 Dec; 537():112-117. PubMed ID: 36252692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular and functional characterization of familial chylomicronemia syndrome.
    Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis.
    Ueda M; Dunbar RL; Wolska A; Sikora TU; Escobar MDR; Seliktar N; deGoma E; DerOhannessian S; Morrell L; McIntyre AD; Burke F; Sviridov D; Amar M; Shamburek RD; Freeman L; Hegele RA; Remaley AT; Rader DJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1454-1457. PubMed ID: 28201738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report.
    Makhmudova U; Schulze PC; Lorkowski S; März W; Geiling JA; Weingärtner O
    J Med Case Rep; 2024 Jun; 18(1):278. PubMed ID: 38872171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    Paquette M; Amyot J; Fantino M; Baass A; Bernard S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lipoprotein lipase: a multifunctional enzyme in lipoprotein metabolism].
    Foubert L; Benlian P; Turpin G
    Presse Med; 1996 Feb; 25(5):207-10. PubMed ID: 8729382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28.
    Kaiser K; Fox RS; Perschon C; Vera-Llonch M; Alonso J; Cubells L; Cella D
    Qual Life Res; 2023 Feb; 32(2):605-614. PubMed ID: 36310187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Encephalopathy in type I hyperlipidemia.
    Onal H; Atugluzeybek C; Alhaj S; Altun G
    Indian Pediatr; 2007 Apr; 44(4):306-8. PubMed ID: 17468530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention.
    Wilson LM; Cross RR; Duell PB
    J Clin Lipidol; 2018; 12(1):240-242. PubMed ID: 29195809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations.
    Vigna GB; Citroni N; Tarugi P; Fellin R
    J Clin Lipidol; 2022; 16(5):591-595. PubMed ID: 35945124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Familial chylomicronemia syndrome: The first case reported in Ecuador.
    Garay García KJ; Chong Menendez RJ; Nogueira JP; Piedra Andrade JS
    Clin Investig Arterioscler; 2022; 34(6):326-329. PubMed ID: 36184299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.
    Koopal C; Bemelmans R; Marais AD; Visseren FL
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30948399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia.
    Paquette M; Bernard S; Hegele RA; Baass A
    Atherosclerosis; 2019 Apr; 283():137-142. PubMed ID: 30655019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency.
    Xia Y; Zheng W; Du T; Gong Z; Liang L; Wang R; Yang Y; Zhang K; Lu D; Chen X; Sun Y; Sun Y; Xiao B; Qiu W
    J Clin Lipidol; 2023; 17(6):808-817. PubMed ID: 37858495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.
    Akoumianakis I; Zvintzou E; Kypreos K; Filippatos TD
    Curr Atheroscler Rep; 2021 Mar; 23(5):20. PubMed ID: 33694000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
    Stroes ESG; Alexander VJ; Karwatowska-Prokopczuk E; Hegele RA; Arca M; Ballantyne CM; Soran H; Prohaska TA; Xia S; Ginsberg HN; Witztum JL; Tsimikas S;
    N Engl J Med; 2024 May; 390(19):1781-1792. PubMed ID: 38587247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-sense oligonucleotide therapies for the treatment of hyperlipidaemia.
    Wierzbicki AS; Viljoen A
    Expert Opin Biol Ther; 2016 Sep; 16(9):1125-34. PubMed ID: 27248482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Updates in Drug Treatment of Severe Hypertriglyceridemia.
    Gouni-Berthold I; Schwarz J; Berthold HK
    Curr Atheroscler Rep; 2023 Oct; 25(10):701-709. PubMed ID: 37642858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.